COX is found in 1 entries

COX as free ligands, exist in 1 entries. Examples include 2AW1,

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Identifiers 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
Formula C16 H14 N2 O3 S
Molecular Weight 314.36 g/mol
Type non-polymer
Isomeric SMILES Cc1onc(c1-c1ccc(cc1)S(N)(=O)=O)-c1ccccc1
InChI InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)

Chemical Details

Formal Charge 0
Atom Count 36
Chiral Atom Count 0
Chiral Atoms
Bond Count 38
Aromatic Bond Count 19

Drug Info: DrugBank

DrugBank ID DB00580   (Stereoisomeric match)
Name Valdecoxib
  • investigational
  • withdrawn
Description Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
Brand Names Bextra
Affected Organism Humans and other mammals
Indication For the treatment of osteoarthritis and dysmenorrhoea
Pharmacology Valdecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is classified as a nonsteroidal anti-inflammatory drug (NSAID). Valdecoxib is used for its anti-inflammatory, analgesic, and antipyretic activities in the management of osteoarthritis (OA) and for the treatment of dysmenorrhea or acute pain. Unlike celecoxib, valdecoxib lacks a sulfonamide chain and does not require CYP450 enzymes for metabolism.
Mechanism of action Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane. Valdecoxib selectively inhibits the cyclooxygenase-2 (COX-2) enzyme, important for the mediation of inflammation and pain. Unlike non-selective NSAIDs, valdecoxib does not inhibit platelet aggregation.
Categories Anti-Inflammatory Agents, Non-Steroidal
ATC-Code M01AH03
CAS number 181695-72-7

Drug Targets

Name Sequence Search Pharmacological Action Actions
Prostaglandin G/H synthase 2 Search yes inhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682